CTT Pharmaceutical Holdings, Inc.
CTTH
$0.0601
-$0.0049-7.54%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2,326.64% | 5,913.44% | 4,750.28% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2,326.64% | 5,913.44% | 4,750.28% | -- | -- |
| Operating Income | -2,326.64% | -5,913.44% | -4,750.28% | -- | -- |
| Income Before Tax | -3,033.58% | -7,273.66% | -5,186.39% | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3,033.58% | -7,273.66% | -5,186.39% | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,033.58% | -7,273.66% | -5,186.39% | -- | -- |
| EBIT | -2,326.64% | -5,913.44% | -4,750.28% | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -2,314.71% | -5,192.31% | -674.63% | -- | -- |
| Normalized Basic EPS | -2,342.86% | -5,275.00% | -653.49% | -- | -- |
| EPS Diluted | -2,314.71% | -5,192.31% | -674.63% | -- | -- |
| Normalized Diluted EPS | -2,342.86% | -5,275.00% | -653.49% | -- | -- |
| Average Basic Shares Outstanding | 35.31% | 27.93% | 55.41% | -- | -- |
| Average Diluted Shares Outstanding | 35.31% | 27.93% | 55.41% | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |